Crawford Must Answer “Tough Questions” During Confirmation – Grassley
This article was originally published in The Tan Sheet
Executive Summary
Sen. Charles Grassley (R-Iowa) is noncommittal on the nomination of FDA Acting Commissioner Lester Crawford to fill the post on a permanent basis
You may also be interested in...
Sen. Grassley’s Proposed Drug Safety Office Would Have Labeling Authority
Sen. Charles Grassley (R-Iowa) will propose legislation creating an independent drug safety office at FDA that would have authority to alter drug labeling and possibly suspend direct-to-consumer advertising
Crawford Nomination Suggests Stability For Supplements, OTC Regulation
Confirmation of Lester Crawford as permanent FDA commissioner would provide the consumer health industries with a known variable for at least the next four years
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC